Karthik Sathiyamoorthy
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Cytomegalovirus and herpesvirus research, Viral-associated cancers and disorders, Bacterial Genetics and Biotechnology, Monoclonal and Polyclonal Antibodies Research, Herpesvirus Infections and Treatments
Most-Cited Works
- → Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus(2017)212 cited
- → Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange(2016)127 cited
- → Structural basis for Epstein–Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins(2016)110 cited
- → The COMPLEXity in herpesvirus entry(2017)96 cited
- → Assembly and Architecture of the EBV B Cell Entry Triggering Complex(2014)94 cited
- → Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus(2016)62 cited
- → Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies(2017)38 cited
- → The Crystal Structure ofEscherichia coliGroup 4 Capsule Protein GfcC Reveals a Domain Organization Resembling That of Wza(2011)34 cited
- → Cycling of Etk and Etp Phosphorylation States Is Involved in Formation of Group 4 Capsule by Escherichia coli(2012)28 cited
- → The Conserved Disulfide Bond within Domain II of Epstein-Barr Virus gH Has Divergent Roles in Membrane Fusion with Epithelial Cells and B Cells(2014)22 cited